Trial Number

404-23

Condition

Pediatric Cancer

Participant Age Range

1 year to 30 years

Participant Gender

Any

Enrolling Participants

Yes

Overview

“A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL)”

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma.

Provider

Jacqueline N Casillas, MD

Hematology-Oncology - Pediatric
Long Beach, Torrance
View Profile

Location

Miller Children’s & Women’s Hospital Long Beach

2801 Atlantic Avenue
Long Beach
(562) 933-5437
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Pediatric Care Miller Children's & Women's Hospital Long Beach
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.